D. Scherer

1.2k total citations
55 papers, 886 citations indexed

About

D. Scherer is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, D. Scherer has authored 55 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 21 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in D. Scherer's work include Cardiac electrophysiology and arrhythmias (23 papers), Ion channel regulation and function (20 papers) and Lipoproteins and Cardiovascular Health (9 papers). D. Scherer is often cited by papers focused on Cardiac electrophysiology and arrhythmias (23 papers), Ion channel regulation and function (20 papers) and Lipoproteins and Cardiovascular Health (9 papers). D. Scherer collaborates with scholars based in Germany, Australia and United States. D. Scherer's co-authors include Stephen J. Nicholls, Hugo A. Katus, Edgar Zitron, Dierk Thomas, Christoph A. Karle, Peter J. Psaltis, Claudia Seyler, John J.P. Kastelein, Eberhard P. Scholz and Steven E. Nissen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

D. Scherer

51 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Scherer Germany 16 369 359 342 151 91 55 886
Carole Amant France 15 397 1.1× 296 0.8× 134 0.4× 244 1.6× 63 0.7× 26 847
Alfonso Campanile Italy 13 257 0.7× 451 1.3× 130 0.4× 71 0.5× 99 1.1× 29 861
Estefanía Tarazón Spain 18 348 0.9× 458 1.3× 214 0.6× 163 1.1× 31 0.3× 63 957
Eiji Yahiro Japan 16 468 1.3× 242 0.7× 184 0.5× 158 1.0× 20 0.2× 36 813
Elaine J. Tanhehco United States 18 431 1.2× 193 0.5× 187 0.5× 115 0.8× 32 0.4× 29 827
Jon Vincelette United States 15 228 0.6× 205 0.6× 123 0.4× 128 0.8× 47 0.5× 24 775
Boris Aleil France 11 565 1.5× 161 0.4× 505 1.5× 88 0.6× 53 0.6× 22 1.3k
Snehal Desai United States 7 168 0.5× 423 1.2× 186 0.5× 82 0.5× 41 0.5× 15 813
Gloria Francolini Italy 14 481 1.3× 401 1.1× 144 0.4× 79 0.5× 35 0.4× 21 1.1k
Corinne Berthonneche Switzerland 17 327 0.9× 467 1.3× 146 0.4× 46 0.3× 35 0.4× 23 882

Countries citing papers authored by D. Scherer

Since Specialization
Citations

This map shows the geographic impact of D. Scherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Scherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Scherer more than expected).

Fields of papers citing papers by D. Scherer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Scherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Scherer. The network helps show where D. Scherer may publish in the future.

Co-authorship network of co-authors of D. Scherer

This figure shows the co-authorship network connecting the top 25 collaborators of D. Scherer. A scholar is included among the top collaborators of D. Scherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Scherer. D. Scherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicholls, Stephen J., Nitesh Nerlekar, D. Scherer, et al.. (2023). Asia-Pacific Investigators and Asian Enrollment in Cardiometabolic Trials. JACC Asia. 3(5). 724–735. 9 indexed citations
2.
Rahm, Ann‐Kathrin, D. Scherer, Claudia Seyler, et al.. (2022). Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP2 binding. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(4). 659–667. 1 indexed citations
3.
Tada, Hayato, Khung Keong Yeo, Jian‐Jun Li, et al.. (2021). Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region. JACC Asia. 1(3). 294–302. 8 indexed citations
4.
Scholz, Eberhard P., Patrick Lugenbiel, Patrick A. Schweizer, et al.. (2018). Novel approach to discriminate left bundle branch block from nonspecific intraventricular conduction delay using pacing-induced functional left bundle branch block. Journal of Interventional Cardiac Electrophysiology. 53(3). 347–355. 2 indexed citations
5.
Nicholls, Stephen J., Rishi Puri, Todd J. Anderson, et al.. (2018). Effect of Evolocumab on Coronary Plaque Composition. Journal of the American College of Cardiology. 72(17). 2012–2021. 98 indexed citations
6.
Scherer, D., Benedikt Schworm, Claudia Seyler, et al.. (2017). Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(7). 701–710. 10 indexed citations
7.
Bartolo, Belinda A. Di, D. Scherer, Alex Brown, Peter J. Psaltis, & Stephen J. Nicholls. (2017). PCSK9 Inhibitors in Hyperlipidemia: Current Status and Clinical Outlook. BioDrugs. 31(3). 167–174. 13 indexed citations
8.
Andrews, Jordan, Tracy Nguyen, Anthony D. Pisaniello, et al.. (2017). Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study. Cardiovascular Diagnosis and Therapy. 7(1). 45–51. 44 indexed citations
9.
Scherer, D., Claudia Seyler, Eberhard Scholz, et al.. (2017). Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP2-interference. Journal of Pharmacology and Experimental Therapeutics. 361(2). 209–218. 7 indexed citations
10.
Scherer, D., et al.. (2016). Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with 18F positron emission tomography. Cardiovascular Diagnosis and Therapy. 6(4). 354–367. 11 indexed citations
11.
Scherer, D., et al.. (2015). Kounis syndrome and hypersensitivity myocarditis – One and the same? Insights from cardiac magnetic resonance imaging. Journal of Cardiology Cases. 12(4). 119–122. 3 indexed citations
12.
Nicholls, Stephen J. & D. Scherer. (2015). Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?. Vascular Health and Risk Management. 11. 203–203. 11 indexed citations
13.
Seyler, Claudia, D. Scherer, Eberhard Scholz, et al.. (2014). Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224. Naunyn-Schmiedeberg s Archives of Pharmacology. 387(12). 1153–1161. 6 indexed citations
14.
Korkmaz, Sevil, Edgar Zitron, Claudia Seyler, et al.. (2013). Provocation of an Autoimmune Response to Cardiac Voltage-Gated Sodium Channel NaV1.5 Induces Cardiac Conduction Defects in Rats. Journal of the American College of Cardiology. 62(4). 340–349. 26 indexed citations
15.
Zitron, Edgar, Claudia Seyler, D. Scherer, et al.. (2013). Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(11). 991–999. 18 indexed citations
16.
Seyler, Claudia, D. Scherer, Eberhard P. Scholz, et al.. (2012). Inhibition of cardiac Kir2.1–2.3 channels by beta3 adrenoreceptor antagonist SR 59230A. Biochemical and Biophysical Research Communications. 424(2). 315–320. 5 indexed citations
17.
Scherer, D., David Hassel, Ramona Bloehs, et al.. (2009). Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents. British Journal of Pharmacology. 156(2). 226–236. 31 indexed citations
18.
Sievert, H., et al.. (2008). Langzeitdilatation bei erfolgloser perkutaner transluminaler Koronarangioplastie. DMW - Deutsche Medizinische Wochenschrift. 119(43). 1458–1461. 2 indexed citations
19.
Kiesecker, Claudia, Edgar Zitron, D. Scherer, et al.. (2005). Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1. Journal of Molecular Medicine. 84(1). 46–56. 24 indexed citations
20.
Thomas, Daniel, Kaichun Wu, Eckhard Ficker, et al.. (2004). Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X). Cardiovascular Research. 64(3). 467–476. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carole Amant Breakdown of academic impact, for papers by Alfonso Campanile Breakdown of academic impact, for papers by Estefanía Tarazón Breakdown of academic impact, for papers by Eiji Yahiro Breakdown of academic impact, for papers by Elaine J. Tanhehco Breakdown of academic impact, for papers by Jon Vincelette Breakdown of academic impact, for papers by Boris Aleil Breakdown of academic impact, for papers by Snehal Desai Breakdown of academic impact, for papers by Gloria Francolini Breakdown of academic impact, for papers by Corinne Berthonneche
Rankless by CCL
2026